These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 39044437)

  • 1. Discovery of NO Donor-Aurovertin Hybrids as Dual Ferroptosis and Apoptosis Inducers for Treating Triple Negative Breast Cancer.
    Ma LF; Xu LL; Yuan LJ; Yang X; Wu R; Bao SM; Chen YL; Duan HL; Fang L; Zhao HJ; Zhan ZJ
    J Med Chem; 2024 Aug; 67(15):13089-13105. PubMed ID: 39044437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a small molecule as inducer of ferroptosis and apoptosis through ubiquitination of GPX4 in triple negative breast cancer cells.
    Ding Y; Chen X; Liu C; Ge W; Wang Q; Hao X; Wang M; Chen Y; Zhang Q
    J Hematol Oncol; 2021 Jan; 14(1):19. PubMed ID: 33472669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of novel 1,8-naphthalimide piperazinamide based benzenesulfonamides derivatives as potent carbonic anhydrase IX inhibitors and ferroptosis inducers for the treatment of triple-negative breast cancer.
    Liang Q; Zhang S; Liu J; Zhou X; Syamimi Ariffin N; Wei J; Shi C; Ma X; Zhang Y; Huang R
    Bioorg Chem; 2024 Sep; 150():107596. PubMed ID: 38941699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aurovertin B exerts potent antitumor activity against triple-negative breast cancer
    Wu R; Yang X; Zhou Q; Yu W; Li M; Wo J; Shan W; Zhao H; Chen Y; Zhan Z
    Pharmazie; 2020 Jun; 75(6):261-265. PubMed ID: 32539922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutathione-Disrupting Nanotherapeutics Potentiate Ferroptosis for Treating Luminal Androgen Receptor-Positive Triple-Negative Breast Cancer.
    Li J; Wu Y; Li Y; Zhu H; Zhang Z; Li Y
    ACS Nano; 2024 Oct; 18(39):26585-26599. PubMed ID: 39287044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ononin triggers ferroptosis-mediated disruption in the triple negative breast cancer both in vitro and in vivo.
    Gong G; Wan Y; Liu Y; Zhang Z; Zheng Y
    Int Immunopharmacol; 2024 May; 132():111959. PubMed ID: 38554442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indole-2-Carboxamide Derivative LG25 Inhibits Triple-Negative Breast Cancer Growth By Suppressing Akt/mTOR/NF-κB Signalling Pathway.
    Xu X; Rajamanickam V; Shu S; Liu Z; Yan T; He J; Liu Z; Guo G; Liang G; Wang Y
    Drug Des Devel Ther; 2019; 13():3539-3550. PubMed ID: 31631978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and docking studies of novel 4-aminophenol-1,2,4-oxadiazole hybrids as apoptosis inducers against triple negative breast cancer cells targeting MAP kinase.
    Dhanalakshmi B; Anil Kumar BM; Srinivasa Murthy V; Srinivasa SM; Vivek HK; Sennappan M; Rangappa S
    J Biomol Struct Dyn; 2024 Jul; 42(11):5841-5857. PubMed ID: 37529915
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Shen JJ; Yang X; Yu M; Li QC; Wang RY; Yu WY; Zhang JL; Chen YL; Zhu WT; Li J; Zhan ZJ; Wu R
    J Pharmacol Exp Ther; 2024 Jun; ():. PubMed ID: 38849141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chloroform Fraction of Methanolic Extract of Seeds of Annona muricata Induce S Phase Arrest and ROS Dependent Caspase Activated Mitochondria-Mediated Apoptosis in Triple-Negative Breast Cancer.
    Kariyil BJ; Ayyappan UPT; Gopalakrishnan A; George AJ
    Anticancer Agents Med Chem; 2021; 21(10):1250-1265. PubMed ID: 32951586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel small molecule STAT3 inhibitor SLSI-1216 suppresses proliferation and tumor growth of triple-negative breast cancer cells through apoptotic induction.
    Park SK; Byun WS; Lee S; Han YT; Jeong YS; Jang K; Chung SJ; Lee J; Suh YG; Lee SK
    Biochem Pharmacol; 2020 Aug; 178():114053. PubMed ID: 32450253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Withanolides from
    Huang L; Wei Y; Ni M; Hu H; Xi L; Wang C; Zhu Z; Yang B; Zhao H
    Molecules; 2024 Apr; 29(8):. PubMed ID: 38675657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural Product-Inspired Discovery of Naphthoquinone-Furo-Piperidine Derivatives as Novel STAT3 Inhibitors for the Treatment of Triple-Negative Breast Cancer.
    Fan C; Lou S; Shen C; Liao J; Ni H; Chen S; Zhu Z; Hu X; Xie W; Zhao H; Cui S
    J Med Chem; 2024 Sep; 67(17):15291-15310. PubMed ID: 39226127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of a novel small-molecule inhibitor of Fam20C that induces apoptosis and inhibits migration in triple negative breast cancer.
    Zhao R; Fu L; Yuan Z; Liu Y; Zhang K; Chen Y; Wang L; Sun D; Chen L; Liu B; Zhang L
    Eur J Med Chem; 2021 Jan; 210():113088. PubMed ID: 33316691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-Assembly Dual-Responsive NO Donor Nanoparticles for Effective Cancer Therapy.
    Gu G; Chen C; Zhang S; Yin B; Wang J
    ACS Appl Mater Interfaces; 2021 Nov; 13(43):50682-50694. PubMed ID: 34668695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A styrylpyrone dimer isolated from Aniba heringeri causes apoptosis in MDA-MB-231 triple-negative breast cancer cells.
    de Souza KFS; Tófoli D; Pereira IC; Filippin KJ; Guerrero ATG; Paredes-Gamero EJ; de Fatima Cepa Matos M; Garcez WS; Garcez FR; Perdomo RT
    Bioorg Med Chem; 2021 Feb; 32():115994. PubMed ID: 33477019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of Orally Bioavailable and Potent CDK9 Inhibitors for Targeting Transcription Regulation in Triple-Negative Breast Cancer.
    Wang WJ; Gao L; Wang S; Huang W; Meng XY; Hu H; Chen Z; Sun J; Yuan Y; Zhou Y; Diao X; Huang R; Li J; Chen XH
    J Med Chem; 2024 Jun; 67(12):10035-10056. PubMed ID: 38885173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shuganning injection, a traditional Chinese patent medicine, induces ferroptosis and suppresses tumor growth in triple-negative breast cancer cells.
    Du J; Wang L; Huang X; Zhang N; Long Z; Yang Y; Zhong F; Zheng B; Lan W; Lin W; Ma W
    Phytomedicine; 2021 May; 85():153551. PubMed ID: 33827043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel nitric oxide-releasing derivatives of farnesylthiosalicylic acid: synthesis and evaluation of antihepatocellular carcinoma activity.
    Ling Y; Ye X; Zhang Z; Zhang Y; Lai Y; Ji H; Peng S; Tian J
    J Med Chem; 2011 May; 54(9):3251-9. PubMed ID: 21504204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of 8,9-seco-
    Fan RZ; Chen L; Su T; Li W; Huang JL; Sang J; Tang GH; Yin S
    J Med Chem; 2021 Jul; 64(14):9926-9942. PubMed ID: 34236840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.